Partner With Us NRI

Vedanta, Granules India, Jindal Stainless to be watched

Published on Mar 29, 2023 08:44

Vedanta: The board of directors of the company approved the fifth interim dividend of Rs 20.50 per equity share on face value of Rs 1 per share for the financial year 2022-23. The record date for the purpose of payment of dividend is 7 April 2023.

Granules India: The US Food & Drug Administration (USFDA) has approved Granules India`s Abbreviated New Drug Application (ANDA) for Gabapentin tablets USP, 600 mg and 800 mg. The drug is bioequivalent to the reference listed drug product (RLD), Neurontin tablets, 600 mg and 800 mg, of Viatris Specialty LLC.

Zydus Lifesciences: Zydus Lifesciences (including its subsidiaries/affiliates) has received final approval for Loperamide Hydrochloride Capsules USP, 2 mg (USRLD: Imodium Capsules) from the United States Food and Drug Administration (USFDA).

Jindal Stainless (JSL): JSL entered into a collaboration agreement with New Yaking Pte. Ltd. for the investment in, development, construction and operation of a Nickel Pig Iron (NPI) smelter facility located in an industrial park in Halmahera Islands, Indonesia. JSL will acquire a 49% equity interest for a consideration of around $157 million.

SML Isuzu: The company has decided to increase the prices of its vehicles (both trucks & buses) with effect from 1st April 2023.

G R Infraprojects: G R Infraprojects has received Letter of Acceptance for a project `Construction of Tunnel work & allied works of Khurda - Bolangir new rail line project in east coast railway`. The estimated project is worth Rs 587.59 crore.

RPP Infra Projects: RPP Infra Projects received a letter of acceptance for a new project viz,` Repair & Construction works of old Buildings for Reopening of old District Jail at Bareilly Uttar Pradesh on EPC Basis. The contract price is Rs 148.08 crore and is expected to be completed up to 31st October 2024.

Powered by Capital Market - Live News